JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
Clinical trial NCT06595186 · RECRUITING
Trial details
- NCT number
- NCT06595186
- Sponsor
- JenKem Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2026-08-16
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.